Pitt’s Clinical and Translational Science Institute Awards $900k to Support Urgent COVID-19 Research
- SARS-CoV-2 Clinical and Community Serosurveillance, Principal Investigators (co-PIs) Paul Duprex, Ph.D., Anita McElroy, M.D., Ph.D., and Alan Wells, M.D., D.M.Sc.
- Biomarkers for Predicting Viral Pneumonia Severity, PI John Alcorn, Ph.D.
- Cellular Mechanisms of SARS-CoV-2 Infection, co-PIs Sally Wenzel, M.D., and Xiuxia Zhou, Ph.D.
- Coronavirus and Lung Microbiome Interactions, PI Georgios Kitsios, M.D., Ph.D.
- COVID-19 Neurologic Manifestations, PI Sherry Hsiang-Yi Chou, M.D., M.M.Sc.
- COVID-Insight Triage and Monitoring Tool, PI David Salcido, Ph.D., M.P.H.
- Determinants of COVID-19 Clinical Outcomes, co-PIs Christian Fernandez, Ph.D., Ernesto Marques, M.D., Ph.D., Donald Burke, M.D., and Philip Empey, Pharm.D., Ph.D.
- Generation of Transgenic hACE2 Knock-in Mice, co-PIs Andrea Gambotto, M.D., Lou Falo, M.D., Ph.D., Mark Shlomchik, M.D., Ph.D., and William Klimstra, Ph.D.
- Impact of Maternal COVID-19 Infection on Newborns, co-PIs Anne-Marie Rick, M.D., M.P.H., and Judith Martin, M.D.
- Lung-Targeting SARS-CoV-2 Therapeutic, PI Raymond Frizzell, Ph.D.
- Modeling Strategies for the COVID-19 Pandemic, PI Mark Roberts, M.D.
- Pediatric Epidemiology SARS-CoV-2 Antibody Response, co-PIs Sarah Wheeler, Ph.D., Glenn Rapsinski, M.D., Ph.D., and Megan Culler Freeman, M.D., Ph.D.
- SARS-CoV-2 Cellular Imaging System, PI Zandrea Ambrose, Ph.D.
- SARS-CoV-2 Immune Escape Variants in Treatment, PI Jana Jacobs, Ph.D.
- SARS-CoV-2 Prevention Spray, co-PIs Lisa Rohan, Ph.D., and Sravan Kumar Patel, Ph.D.
- Therapeutic Nanobodies for SARS-CoV-2, PI Yi Shi, Ph.D.
- Therapy for COVID-19 Induced ARDS, PI Luis Ortiz, M.D.